Studies have shown that people with DM have lower risk of developing prostate cancer (PCa) compared with non-diabetics.1, 2 This may be due to altered hormone milieu in diabetic men or lower prostate-specific antigen (PSA) leading to less prostate biopsies due to elevated PSA. Here, KLK3 is linked to posterior cortical atrophy.